Drug Type Small molecule drug |
Synonyms Orbit azine fumarate, 富马酸奥比特嗪肠溶微丸胶囊, SM-1 |
Target |
Mechanism caspase 3 activators(Caspase-3 activators) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Initiation and Maintenance Disorders | Phase 3 | US | 09 Oct 2017 | |
Advanced Triple-Negative Breast Carcinoma | Phase 2 | CN | 21 Apr 2023 | |
Adenocarcinoma of small intestine | Phase 2 | CN | 03 Jan 2023 | |
Colorectal Cancer | Phase 2 | - | - | |
Glioblastoma | Phase 1 | CN | 19 Sep 2022 | |
Recurrent Lymphoma | Phase 1 | CN | 30 Jan 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 27 Apr 2020 | |
Locally Advanced Head and Neck Squamous Cell Carcinoma | IND Approval | CN | 14 Oct 2022 |
Phase 2 | 39 | fjpvshcgfi(pdvjvjxonl) = loyjmuqgel tuvzlfqyeq (hrjavbnlly ) | Positive | 01 Nov 2019 | |||
Phase 2 | 39 | (Treatment) | yfuobnzmls(kajivprpou) = ktkxubukso iibyzgwjwo (bxaojjzmmt, qdbrvxwoum - lrbeqtpsge) View more | - | 06 Mar 2018 | ||
(Comparator) | yfuobnzmls(kajivprpou) = skoclidayi iibyzgwjwo (bxaojjzmmt, ghqgkfdocc - upyfsuhpqw) View more |